RTH 112Pathophysiology of the Cardiopulmonary Systems - PowerPoint PPT Presentation

1 / 25
About This Presentation
Title:

RTH 112Pathophysiology of the Cardiopulmonary Systems

Description:

Worries, but does nothing to fix. the problem, until afterwards... U. Are ... Inhalation of toxic gases 'SMOKING' is the most common. Inhalation of antigens ... – PowerPoint PPT presentation

Number of Views:72
Avg rating:3.0/5.0
Slides: 26
Provided by: jsdhe
Category:

less

Transcript and Presenter's Notes

Title: RTH 112Pathophysiology of the Cardiopulmonary Systems


1
RTH 112-Pathophysiology of the Cardiopulmonary
Systems
  • Joseph S. DiPietro, Ph.D., RRT
  • Professor and Director, Respiratory Care Programs
  • Co-Director, Health Technologys Education

2
Pathophysiology
  • The study of abnormal function and its
    relationship to disease
  • In this course, our focus will be the
    cardiopulmonary systems
  • Your text--Textbook of Pulmonary Disease, Baum

3
Your responsibilities
  • Pre-read your assignments before class
  • We only have 9 and 1/4 weeks to cover 15 weeks of
    material
  • Key to this--your preparation
  • This is an open forum classroom--if your are not
    prepared, discussion with you will prove difficult

4
Your responsibilities
  • Much of the presentation will also tie in things
    youve already had, like physiology and physics
    and chemistry
  • If you dont understand--
  • ASK!!!!!!!!!!!!!!!

5
Dont act like this person...
Worries, but does nothing to fix the problem,
until afterwards...
6
U
Are ultimately responsible...for your grades
knowledge YOURSELF!!!
7
The Obstructive Lung Diseases
  • Bronchitis
  • Emphysema
  • Asthma

8
Bronchitis
  • Inflammation of the conducting zone airways
  • Characterized by increased secretion production
  • Considered chronic if...sputum production exists
    for three consecutive weeks for two consecutive
    months

9
Features
  • PaO2s lt 50 torr
  • PaCO2s gt 50 torr
  • pH normal (usually just shy of 7.40)
  • increased secretions
  • Old nickname blue bloater
  • R heart failure, or right CHF (cor pulmonale)
  • polycythemia
  • increased A-P diameter due to air trapping
  • Decreased breath sounds w/air trapping rhonchi

10
Causes
  • Inhalation of toxic gases
  • SMOKING is the most common
  • Inhalation of antigens
  • Inhalation of viruses or bacteria

11
Emphysema
  • In Greek, this word means swollen with air
  • There are two primary types of this disease
  • Panlobar, which affects the acinus or alveolar
    groups-- usually a genetic predisposition due to
    Alpha 1, antitrypsin deficiency
  • Centralobar, which affects respiratory
    bronchioles--smoking is the cause

12
Features
  • Increased A-P diameter
  • Increased CO2s and decreased PO2s, late
  • Old nickname pink puffer
  • little or no secretions
  • loss of gas surface area for diffusion
  • skinny (the better term might be hyposthenic)
  • Diminished breath sounds

13
Causes
  • SMOKING
  • Genetics
  • Bronchitis
  • Asthma

14
Pulmonary Function in Chronic Airways Obstruction
  • Decreased expiratory flowrates such as the
    FEF200-1200 and FEF25-75 as well as FEV1
  • Increased residual volume, functional residual
    capacity and total lung capacity
  • Decreased capacity of diffusion DLCO

15
Bronchitis v. Emphysema
  • Easy to decompensate
  • Usually relatively easy to treat
  • Can cause emphysema
  • Rarely are these patients ever having normal
    blood gases
  • Usually more difficult to decompensate
  • Difficult to treat
  • Can be caused by bronchitis
  • Early, blood gases are normal

16
Gas Exchange is poor because
  • Loss of alveolar structure base thereby causing
    decreased gas exchange surface area
  • Mechanically, elastance is lost due to the
    constant stretching of distal airways
  • Consequently, these patients are very compliant,
    because the natural tendency for the lung to
    collapse is inadvertently lost

17
Asthma
  • Known too, as the disease of reversible airways
    obstruction or reactive airways disease
  • More deaths were associated with asthma in
    children in 1996 and 97 than in any time in
    documented history
  • Commonly caused by the TYPE I Hypersensitivity
    Reaction or the Mast Cell Reaction

18
Hypersensitivity Reactions
  • TYPE I-- Mast cell degraulation resulting from
    antigen attachment and release of allergic
    mediators
  • TYPE II--antigen-antibody complex seen in
    transfusion reactions
  • TYPE III-- ARTHUS REACTION or localized
    antigen-antibody reactions such as hives
  • TYPE IV-- delayed hypersensitivity such as
    pulmonary TB

19
In Extrinsic Asthma (caused by an external source)
  • The antigen attaches to the Mast Cell causing an
    antibody response (typically IgE)
  • The mast cell degranulates and releases allergic
    mediators to remove the antigen

20
The Released Mediators
  • Histamine---causing bronchoconstriction
  • Bradykinin--causing vasodilation
  • Leukotrienes--causing bronchconstriction and
    vasodilation (Formerly known as SRS-A)
  • ECF-A--Eosinophilic Chemotactic Factor of
    Anaphylaxis causing eosinophils to go to the
    sight of reaction
  • PAF--Platelet Activating Factor causing
    production migration of platelets to sight of
    reaction
  • Thromboxanes--causing bronchoconstriction and
    vasodilation

21
The Mast Cell Reaction---
  • Is a natural response in all people
  • But in asthmatics, it is greatly accelerated
  • Hence, hypersensitivity

22
Asthma--the 2 types
  • Extrinsic--caused by external sources such as
    pollen, bacteria, viruses, mold spores
  • Instrinsic--caused by internal sources such as
    infection, chronic disease, stress phenomena

23
Features
  • Increased secretion production
  • Bronchoconstriction
  • WHEEZING
  • prolonged expiration (increased ETime)
  • air trapping
  • initially, CO2s are decreased and so are PO2s
  • Use of accessory muscles
  • Breath sounds diminished crackles on insp.
  • Increased A-P diameter barrelled chest

24
Asthma-Pulmonary Function
  • Decreased expiratory flow rates
  • Increased residual volume, functional residual
    capacity, and total lung capacity
  • Decreased diffusion
  • Increased work of breathing

25
Asthma-Rx
  • Bronchodilators, parenteral and inhalants
  • Adequate hydration
  • In acute episodes, continuous bronchodilator
    aerosols
  • steroids
  • supplemental oxygen therapy
  • if patient resistant to meds, this is known as
    STATIS ASTHMATICUS, and if CO2s are at 40 torr
    may need mechanical ventilation
Write a Comment
User Comments (0)
About PowerShow.com